140 related articles for article (PubMed ID: 31493939)
21. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
22. Moderate Prognostic Value of lncRNA FOXD2-AS1 in Gastric Cancer with Helicobacter pylori Infection.
Rajabi A; Bastani S; Maydanchi M; Tayefeh-Gholami S; Abdolahi S; Saber A; Safaralizadeh R
J Gastrointest Cancer; 2022 Sep; 53(3):687-691. PubMed ID: 34478035
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
24. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
25. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
26. The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis.
Yang Q; Wang J; Zhong P; Mou T; Hua H; Liu P; Xie F
Cancer Cell Int; 2020; 20():72. PubMed ID: 32165862
[TBL] [Abstract][Full Text] [Related]
27. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
28. lncRNA FAM83H-AS1 is associated with the prognosis of colorectal carcinoma and promotes cell proliferation by targeting the Notch signaling pathway.
Lu S; Dong W; Zhao P; Liu Z
Oncol Lett; 2018 Feb; 15(2):1861-1868. PubMed ID: 29434883
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA FAM83H-AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer.
El-Ashmawy NE; Al-Ashmawy GM; Hamouda SM
Cell Biochem Funct; 2021 Apr; 39(3):350-356. PubMed ID: 33159470
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
Zhang HH; Li AH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
[TBL] [Abstract][Full Text] [Related]
31. FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients.
Ríos-Romero M; Cedro-Tanda A; Peña-Luna M; Mancera-Rodríguez MA; Hidalgo-Pérez L; Cisneros-Villanueva M; Beltrán-Anaya FO; Arellano-Llamas R; Jiménez-Morales S; Alfaro-Ruíz LA; Tenorio-Torres A; Domínguez-Reyes C; Villegas-Carlos F; Ochoa-Mendoza E; Hidalgo-Miranda A
Sci Rep; 2020 Aug; 10(1):14145. PubMed ID: 32839509
[TBL] [Abstract][Full Text] [Related]
32. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
33. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation.
Liu YW; Xia R; Lu K; Xie M; Yang F; Sun M; De W; Wang C; Ji G
Mol Cancer; 2017 Feb; 16(1):39. PubMed ID: 28209170
[TBL] [Abstract][Full Text] [Related]
34. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Li C; Wu R; Xing Y
Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
[TBL] [Abstract][Full Text] [Related]
35. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression.
Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z
Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of PlncRNA-1 and TUG1: potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression.
Baratieh Z; Khalaj Z; Honardoost MA; Emadi-Baygi M; Khanahmad H; Salehi M; Nikpour P
Biomark Med; 2017 Dec; 11(12):1077-1090. PubMed ID: 29182008
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance.
Chen M; Wu X; Ma W; Zhou Q; Wang X; Zhang R; Wang J; Yang X
Cancer Biomark; 2017 Dec; 21(1):23-28. PubMed ID: 29036784
[TBL] [Abstract][Full Text] [Related]
38. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
[TBL] [Abstract][Full Text] [Related]
39. Identification of lncRNA
Yang F; Lv SX; Lv L; Liu YH; Dong SY; Yao ZH; Dai XX; Zhang XH; Wang OC
Onco Targets Ther; 2016; 9():7039-7045. PubMed ID: 27895496
[TBL] [Abstract][Full Text] [Related]
40. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
